Although tumor cells can be immunogenic, and the presence of CD8+ tumor infiltrating lymphocytes was regarded as a positive prognostic factor in multiple solid tumors (Azimi et al., 2012; Bremnes et al., 2016; Pollari et al., 2018), the immune system often fails to eradicate tumor cells in vivo. The gene discussed is CD8A; the disease is neoplasm.